Skip to content

    Recently Viewed

      Listening...

      Home / Latest news / Innovation /
      Quiz: How much do you really know about COVID-19
      Virus graphic

      Quiz: How much do you really know about COVID-19

      Think you are up to speed on the novel coronavirus? Take this quiz to test your virus knowledge.

      Share Article
      share to
      Since January, when the World Health Organization (WHO) announced that it had identified a new virus and declared its outbreak a public health emergency of international concern, COVID-19 has dominated headlines—and our daily lives.

      There is much we have learned about the novel coronavirus, also known as SARS-CoV-2, since then—and much public health experts continue to untangle about the virus seemingly every day.

      Is it mutating? Does warmer weather have any impact on its spread? Are men and women getting sick in the same way?

      Researchers around the world, including those at Johnson & Johnson, are exploring some of these questions as they work hard on identifying investigational vaccine candidates.

      Want to test your own COVID-19 know-how? Take our quiz—and learn more about what it might take to help fight the pandemic.

      1.

      What does COVID-19 stand for?

      2.

      What other viruses belong to the coronavirus family?

      3.

      True or False: A vaccine stimulates your immune system to produce antibodies, like it would if you were exposed to the virus.

      4.

      There are currently vaccines for the following coronaviruses:

      5.

      How many vaccine candidates for COVID-19 have been proposed?

      6.

      True or False: The virus is mutating rapidly.

      7.

      How does weather seem to affect the novel coronavirus?

      8.

      Currently, which group has had more severe effects of COVID-19?

      9.

      True or False: COVID-19 has currently been detected on all seven continents.

      More From Johnson & Johnson

      Innovation
      Hanneke Schuitemaker, Ph.D., Global Head of Viral Vaccine Discovery and Translational Medicine and the Disease Area Stronghold Leader for Viral Vaccines at Janssen Vaccines & Prevention, a Janssen Pharmaceutical Company of Johnson & Johnson

      She’s a scientist with one of the world’s most important jobs: Creating a potential COVID-19 vaccine

      Imagine being a researcher who is staring down not only a highly infectious virus, but one that’s caused the first global pandemic in more than 100 years. Meet Johnson & Johnson’s Hanneke Schuitemaker, Ph.D.
      Latest news
      A collage of photos of healthcare providers and a scientist working on Covid-19

      6 impactful ways Johnson & Johnson is helping in the fight against COVID-19

      From work on an investigational vaccine candidate to a $50 million commitment in support of healthcare workers on the very front lines of the crisis around the world, learn how the company has taken action to help respond to the pandemic.
      Innovation
      Two scientists in a lab

      “I’m racing to screen thousands of molecules": These scientists are canvassing a vast library in search of a potential COVID-19 treatment

      Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
      share
      share to

      Watch “The Road to a Vaccine”

      The video series, hosted by journalist and author Lisa Ling, delves into efforts to create a potential COVID-19 vaccine.

      More from Johnson & Johnson

      Health & wellness
       Intense and extreme heat wave under the sun illustrating the impact of climate change

      Building climate-resilient health clinics

      When Mother Nature strikes—think triple-digit heatwaves, wildfires, hurricanes—vulnerable populations are at risk of missing out on much-needed healthcare. For Earth Day, learn how Johnson & Johnson is helping community clinics protect patients.
      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.